Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | CCR1 | P32246 | 2/20 | 0.38 |
| ▸ | CCR2 | P41597 | 1/20 | 0.38 |
| ▸ | ANXA2 | P07355 | 9/20 | 0.38 |
| ▸ | S100A10 | P60903 | 9/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2295543 | 0.86 | ANXA2 (0.48) | L3MBTL1ANXA2S100A10MGLLALDH1A1 | |
| SCHEMBL2234313 | 0.78 | ANXA2 (0.45) | NPC1RAB9AANXA2S100A10MGLL | |
| SCHEMBL2234748 | 0.67 | ANXA2 (0.44) | L3MBTL1NPC1RAB9ACCR1CCR2 | |
| SCHEMBL15139601 | 0.65 | CCR1 (0.52) | L3MBTL1CCR1CCR2MGLLCES2 | |
| SCHEMBL2230926 | 0.60 | ANXA2 (0.66) | CCR1CCR2ANXA2S100A10ALDH1A1 | |
| SCHEMBL2156105 | 0.59 | CES2 (1.00) | L3MBTL1NPC1RAB9ACES2CES1 | |
| SCHEMBL14135917 | 0.59 | ALDH1A1 (0.76) | L3MBTL1NPC1RAB9ACES2CES1 | |
| SCHEMBL195263 | 0.59 | ALDH1A1 (0.76) | L3MBTL1NPC1RAB9ACES2CES1 | |
| SCHEMBL6224695 | 0.57 | RAB9A (1.00) | L3MBTL1NPC1RAB9ACES2CES1 | |
| SCHEMBL6199337 | 0.57 | RAB9A (1.00) | L3MBTL1NPC1RAB9ACES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011092505-A1 | S100 PROTEIN BINDING INTERACTION INHIBITORS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2011-08-04 | — | — | WO | disclosed |